natgillin/translations-raw huggingface dataset:
Patients must be instructed to always check the insulin label before each injection to avoid accidental mix-ups between NovoMix and other insulin products.
Bolnikom je treba naročiti, da pred vsakim injiciranjem vedno preverijo nalepko na vložku/injekcijskem peresniku in tako preprečijo nenamerno zamenjavo zdravila NovoMix in drugih insulinskih zdravil.
Avoidance of accidental mix-ups/medication errors Patients must be instructed to always check the insulin label before each injection to avoid accidental mix-ups between NovoMix and other insulin products.
Preprečevanje nenamerne zamenjave zdravil/napak pri zdravljenju Bolnikom je treba naročiti, da pred vsakim injiciranjem vedno preverijo nalepko na vložku/injekcijskem peresniku in tako preprečijo nenamerno zamenjavo zdravila NovoMix in drugih insulinskih zdravil.
See How and where to inject, below for information.
Za več informacij glejte podpoglavje Kako in kje injicirati, v nadaljevanju.
Needles, cartridges and pre-filled pens must not be shared.
Igel, vložkov in napolnjenih injekcijskih peresnikov se ne sme deliti z drugimi.
• The other ingredients are glycerol, phenol, metacresol, zinc chloride, disodium phosphate dihydrate, sodium chloride, protamine sulfate, hydrochloric acid, sodium hydroxide and water for injections.
• Druge sestavine zdravila so glicerol, fenol, metakrezol, cinkov klorid, natrijev hidrogenfosfat dihidrat, natrijev klorid, protaminijev sulfat, klorovodikova kislina, natrijev hidroksid in voda za injekcije.
They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
Vključujejo žejo, pogostejše uriniranje, slabost, bruhanje, zaspanost, pordelo suho kožo, suha usta, izgubo apetita in acetonski zadah.
► Your FlexPen must be handled with care.
► Z vašim injekcijskim peresnikom FlexPen morate ravnati previdno.
In one study, 341 patients with type 2 diabetes were randomised to treatment with NovoMix 30 either alone or in combination with metformin, or to metformin together with sulfonylurea.
V eni študiji je bilo 341 bolnikov s sladkorno boleznijo tipa 2 randomiziranih v skupine zdravljene samo z zdravilom NovoMix 30 ali s kombinacijo zdravila NovoMix 30 in metformina ali pa s kombinacijo metformina in sulfonilsečnine.
3 ml suspension in cartridge (type 1 glass) with a plunger (bromobutyl) and a rubber closure (bromobutyl/polyisoprene) contained in a pre-filled multidose disposable pen made of polypropylene.
3 ml suspenzije v vložku (steklo tipa I) z batom (bromobutil) in gumijasto zaporko (bromobutil/poliizopren), vstavljenim v napolnjen večodmeren injekcijski peresnik iz polipropilena, ki se ga zavrže, ko je izrabljen.
► If it has not been stored correctly or if it has been frozen, see section 5, How to store NovoMix
► če ni bilo shranjeno pravilno ali je zamrznilo (glejte poglavje 5, Shranjevanje zdravila NovoMix 30),
In elderly patients (≥65 years old) and in patients with hepatic or renal impairment, glucose monitoring should be intensified and the insulin aspart dose adjusted on an individual basis.
Pri starejših bolnikih (≥ 65 let) in pri bolnikih z jetrno ali ledvično okvaro je treba koncentracijo glukoze v krvi spremljati pozorneje ter odmerek insulina aspart prilagoditi posamezniku.
NovoMix 30 is used to reduce the high blood sugar level in adults, adolescents and children aged 10 years and above with diabetes mellitus (diabetes).
Zdravilo NovoMix 30 se uporablja za znižanje visokega krvnega sladkorja pri odraslih, mladostnikih in otrocih, starih 10 let in več, s sladkorno boleznijo.
Selecting your dose
Izbira odmerka
Dispose of it carefully and put the pen cap back on your FlexPen.
Pazljivo jo zavrzite in na injekcijski peresnik FlexPen znova namestite pokrovček.
Do not use this medicine after the expiry date, which is stated on the FlexPen label and carton after ‘EXP'.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki injekcijskega peresnika FlexPen in škatli poleg oznake ‘Uporabno do'.
Avoidance of accidental mix-ups/medication errors
Preprečevanje nenamerne zamenjave zdravil/napak pri zdravljenju
NovoMix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.
Zdravilo NovoMix 30 je namenjeno zdravljenju sladkorne bolezni pri odraslih, mladostnikih in otrocih, starih 10 let in več.
In patients with type 2 diabetes, NovoMix 30 can be given as monotherapy.
Pri bolnikih s sladkorno boleznijo tipa 2 je mogoče zdravilo NovoMix 30 uporabljati kot monoterapijo.
In type 2 patients with diabetes, the maximum concentration was reached about 95 minutes after dosing.
Pri bolnikih s sladkorno boleznijo tipa 2 je bila največja koncentracija dosežena približno 95 minut po uporabi.
Animal reproduction studies have not revealed any differences between insulin aspart and human insulin regarding embryotoxicity or teratogenicity.
Reprodukcijske študije na živalih niso odkrile razlik v embriotoksičnosti ali teratogenosti med insulinom aspart in humanim insulinom.
The time to maximum concentration is, on average, half of that for biphasic human insulin 30.
Čas do največje koncentracije je v povprečju pol krajši kot pri dvofaznem humanem insulinu 30.
In treatment of type 2 diabetes mellitus, NovoMix 30 may be used in combination with tablets for diabetes and/or with injectable antidiabetic products.
Pri zdravljenju sladkorne bolezni tipa 2 se lahko zdravilo NovoMix 30 uporablja skupaj s tabletami za zdravljenje sladkorne bolezni in/ali z zdravili za zdravljenje sladkorne bolezni v obliki injekcije.
The blood glucose lowering effect of insulin aspart is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.
Mehanizem delovanja in farmakodinamični učinki Učinek insulina aspart na znižanje glukoze v krvi je posledica lažjega privzema glukoze zaradi vezave insulina na insulinske receptorje na mišičnih in maščobnih celicah ter hkratne inhibicije sproščanja glukoze iz jeter.
The pharmacokinetics of NovoMix 30 have not been investigated in children or adolescents.
Farmakokinetika zdravila NovoMix 30 pri otrocih in mladostnikih ni raziskana.
Intensification of insulin therapy with abrupt improvement in glycaemic control may be associated with temporary worsening of diabetic retinopathy, while long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy.
Medtem ko dolgoročno izboljšana urejenost glikemije zmanjša tveganje za napredovanje diabetične retinopatije, lahko intenziviranje insulinskega zdravljenja s hitrim izboljšanjem urejenosti glikemije spremlja prehodno poslabšanje diabetične retinopatije.
Compared to biphasic human insulin 30, administration of NovoMix 30 before breakfast and dinner resulted in lower postprandial blood glucose after both meals (breakfast and dinner).
Uporaba zdravila NovoMix 30 pred zajtrkom in večerjo je v primerjavi z uporabo dvofaznega humanega insulina 30 povzročila nižjo postprandialno glukozo v krvi po obeh obrokih (zajtrk, večerja).
Uncommon - Injection site reactions
Občasno - reakcije na mestu injiciranja
METHOD AND ROUTE OF ADMINISTRATION Read the package leaflet before use Subcutaneous use
POSTOPEK IN POT UPORABE ZDRAVILA Pred uporabo preberite priloženo navodilo.
The maximum serum insulin concentration is, on average, 50% higher with NovoMix 30 than with biphasic human insulin 30.
Največja koncentracija insulina v serumu je pri zdravilu NovoMix 30 v povprečju za 50 % večja kot pri dvofaznem humanem insulinu 30.
• Exercise less than usual.
• ste manj telesno dejavni kot ponavadi.
Limited clinical data exists for children aged 6-9 years.
Pri otrocih od 6. do 9. leta starosti je kliničnih podatkov malo.
L ► Keep the push-button fully depressed and let the needle remain under the skin for at least
► Potisni gumb držite povsem pritisnjen in pustite iglo pod kožo vsaj 6 sekund.
As with any insulin therapy, injection site reactions may occur and include pain, redness, hives, inflammation, bruising, swelling and itching.
Kot pri vsakem zdravljenju z insulinom se lahko pojavijo reakcije na mestu injiciranja, vključno z bolečinami, pordelostjo, koprivnico, vnetjem, podplutbo, oteklino in srbenjem.
A meta-analysis including nine trials in patients with type 1 and type 2 diabetes showed that fasting blood glucose was higher in patients treated with NovoMix 30, than in patients treated with biphasic human insulin 30.
Metaanaliza, ki je zajela devet preskušanj pri bolnikih s sladkorno boleznijo tipa 1 in tipa 2, je pokazala, da je bila glukoza v krvi na tešče višja pri bolnikih, ki so dobivali zdravilo NovoMix 30, kot pri bolnikih, ki so dobivali dvofazni humani insulin 30.
► Do not refill your FlexPen.
► Injekcijskega peresnika FlexPen ne smete znova polniti.
With each injection, change the injection site within the particular area of skin that you use.
Mesto injiciranja na posameznem predelu kože, ki ga uporabljate, menjajte pri vsakem injiciranju.
Do not use this medicinal product if you notice that the resuspended liquid is not uniformly white, cloudy and aqueous.
Zdravila ne uporabite, če opazite, da resuspendirana tekočina ni enakomerno bela, motna in vodna.
The safety and efficacy of NovoMix 50 in children below 18 years of age have not been established.
Varnost in učinkovitost zdravila NovoMix 50 nista ugotovljeni pri otrocih, mlajših od 18 let.
Do not use this medicine after the expiry date, which is stated on the cartridge label and carton after ‘EXP'.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki vložka in škatli poleg oznake ‘Uporabno do'.
The advisability of driving or operating a machine should be considered in these circumstances.
V takšnih okoliščinah je treba pretehtati, ali je priporočljivo, da bolnik vozi ali upravlja s stroji.
After resuspension, the liquid should appear uniformly white, cloudy and aqueous.
Po resuspendiranju mora biti tekočina enakomerno bela, motna in vodna.
+2 units
+ 2 enoti
The safety and efficacy of NovoMix 70 in children below 18 years of age have not been established.
Varnost in učinkovitost zdravila NovoMix 70 nista ugotovljeni pri otrocih, mlajših od 18 let.
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and toxicity to reproduction and development.
Neklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih se odmerkih, genotoksičnosti, vpliva na sposobnost razmnoževanja in razvoja ne kažejo posebnega tveganja za človeka.
Uncommon - Oedema
Občasno - edemi
If the moving procedure alone is not enough to give a uniformly white, cloudy and aqueous liquid, repeat the rolling and moving procedures (see B and C) until the liquid does appear uniformly white, cloudy and aqueous.
Če s tem postopkom ne dobite enakomerno bele, motne in vodne tekočine, ga ponavljajte (glejte B in C), dokler ni tekočina enakomerno bela, motna in vodna.
+4 units
+ 4 enote
Move the pen up and down between the two positions at least 10 times until the liquid does appear uniformly white, cloudy and aqueous.
Obrnite injekcijski peresnik z vložkom vsaj 10-krat gor in dol med obema položajema, dokler ni tekočina enakomerno bela, motna in vodna.
• There is limited experience with NovoMix 30 in children aged 6-9 years.
• Izkušnje z uporabo zdravila NovoMix 30 pri otrocih, starih od 6 do 9 let, so omejene.
NovoMix 30 can be used in adolescents and children aged 10 years and above when premixed insulin is preferred.
Zdravilo NovoMix 30 je mogoče uporabiti pri mladostnikih in otrocih, starih 10 let in več, kadar ima v terapiji prednost uporaba mešanega insulina.
NovoMix 50 which has been frozen must not be used.
Zdravila NovoMix 50, ki je bil zamrznjen, se ne sme uporabiti.
During clinical trials, the overall rates of hypoglycaemia did not differ between patients treated with insulin aspart compared to human insulin.
V kliničnih preskušanjih ni bilo razlik med celotnim deležem hipoglikemij pri bolnikih, zdravljenih z insulinom aspart, in bolnikih, ki so dobivali humani insulin.
NovoMix 70 may fully or partially meet this requirement.
Zdravilo NovoMix 70 lahko to potrebo pokrije v celoti ali delno.
In patients with type 2 diabetes, a dose reduction of 20% is recommended for patients with an HbA1c less than 8% when a GLP-1 receptor agonist is added to NovoMix 30, to minimise the risk of hypoglycaemia.
Pri bolnikih s sladkorno boleznijo tipa 2 in vrednostjo HbA1c manj kot 8 %, ki se jim pri zdravljenju z zdravilom NovoMix 30 dodatno uvede agonist receptorjev GLP-1, je priporočljivo odmerek zdravila
At the beginning of the insulin treatment, refraction anomalies, oedema and injection site reactions (pain, redness, hives, inflammation, bruising, swelling and itching at the injection site) may occur.
Na začetku zdravljenja z insulinom se lahko pojavijo refrakcijske anomalije, edemi in reakcije na mestu injiciranja (bolečina, pordelost, koprivnica, vnetje, podplutba, oteklina in srbenje na mestu injiciranja).
NovoMix 70 which has been frozen must not be used.
Zdravila NovoMix 70, ki je bil zamrznjen, se ne sme uporabiti.
LIST OF EXCIPIENTS glycerol, phenol, metacresol, zinc chloride, disodium phosphate dihydrate, sodium chloride, protamine sulfate, hydrochloric acid/sodium hydroxide for pH adjustment and water for injections
SEZNAM POMOŽNIH SNOVI glicerol, fenol, metakrezol, cinkov klorid, natrijev hidrogenfosfat dihidrat, natrijev klorid, protaminijev sulfat, klorovodikovo kislino/natrijev hidroksid za uravnavanje pH in vodo za injekcije.
NovoMix 70 may be used in combination with metformin.
Zdravilo NovoMix 70 se lahko uporablja v kombinaciji z metforminom.
Resuspending your insulin
Resuspendiranje insulina
Each cartridge contains 300 units of insulin aspart in 3 ml suspension for injection.
En vložek vsebuje 300 enot insulina aspart v 3 ml suspenzije za injiciranje.
+6 units
+ 6 enot
Transfer to NovoMix 70 from other insulin preparations may require adjustment of dose and timing of administration.
Pri prehodu na zdravilo NovoMix 70 z drugih insulinskih zdravil bo morda potrebno prilagoditi odmerek in čas apliciranja.
Each pre-filled pen contains 300 units of insulin aspart in 3 ml suspension for injection.
En napolnjen injekcijski peresnik vsebuje 300 enot insulina aspart v 3 ml suspenzije za injiciranje.
NovoMix 30 Penfill EU/1/00/142/004 EU/1/00/142/005
NovoMix 30 Penfill EU/1/00/142/004
NovoMix 30 which has been frozen must not be used.
Zdravila NovoMix 30, ki je bil zamrznjen, se ne sme uporabiti.
NovoMix 50 is indicated for treatment of diabetes mellitus in adults.
Zdravilo NovoMix 50 je namenjeno zdravljenju sladkorne bolezni pri odraslih.
When transferring a patient from biphasic human insulin to NovoMix 30, start with the same dose and regimen.
Ko bolnik preide z dvofaznega humanega insulina na zdravilo NovoMix 30, morate zdravilo NovoMix 30 uvesti v enakem odmerku in po enaki shemi.
When NovoMix 70 is used in combination with metformin the dose should be adjusted.
Kadar zdravilo NovoMix 70 uporabljate v kombinaciji z metforminom, mora biti odmerek prilagojen.
Continuous rotation of the injection site within the particular area reduces the risk of developing these reactions.
Stalno krožno menjavanje mest injiciranja na posameznem predelu zmanjša tveganje za nastanek teh reakcij.
If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.
Če imate dodatna vprašanja o uporabi zdravila, se posvetujte s svojim zdravnikom, z medicinsko sestro ali s farmacevtom.
When NovoMix 50 is used in combination with metformin the dose should be adjusted.
Kadar zdravilo NovoMix 50 uporabljate v kombinaciji z metforminom, mora biti odmerek prilagojen.
In patients with type 2 diabetes, NovoMix 70 can be given as monotherapy or in combination with metformin when the blood glucose is inadequately controlled with metformin alone.
Pri bolnikih s sladkorno boleznijo tipa 2 lahko zdravilo NovoMix 70 uporabite kot monoterapijo ali v kombinaciji z metforminom, če glukoza v krvi s samim metforminom ni zadostno urejena.
They include: increased urination; feeling thirsty; losing your appetite; feeling sick (nausea or vomiting); feeling drowsy or tired; flushed; dry skin; dry mouth and a fruity (acetone) smell of the breath.
Med njimi so: pogostejše uriniranje, občutek žeje, izguba apetita, občutek slabosti (siljenje na bruhanje ali bruhanje), občutek zaspanosti ali utrujenosti, pordela in suha koža, suha usta in sadni (acetonski) zadah izdihanega zraka.
NovoMix 50 must be protected from excessive heat and light.
Zdravilo NovoMix 50 je treba zaščititi pred čezmerno toploto in svetlobo.
• Repeat the rolling and moving procedures (see pictures A and B) until the liquid appears uniformly white, cloudy and aqueous.
• Ponavljajte postopek vrtenja in obračanja (glejte sliki A in B), dokler ni tekočina enakomerno bela, motna in vodna.
NovoMix 70 must be protected from excessive heat and light.
Zdravilo NovoMix 70 je treba zaščititi pred čezmerno toploto in svetlobo.
The following substances may reduce the patient's insulin requirements: Oral antidiabetic medicinal products, GLP-1 receptor agonists, monoamine oxidase inhibitors (MAOI), beta-blockers, angiotensin converting enzyme (ACE) inhibitors, salicylates, anabolic steroids and sulfonamides.
Bolnikovo potrebo po insulinu lahko zmanjšajo naslednje snovi: peroralni antidiabetiki, agonisti receptorjev GLP-1, zaviralci monoaminooksidaze (MAO), zaviralci adrenergičnih receptorjev beta, zaviralci encima angiotenzinske konvertaze (ACE), salicilati, anabolni steroidi in sulfonamidi.
Mean HbA1c remained similar to baseline throughout the trial in both treatment groups, and there was no difference in hypoglycaemia rate with NovoMix 30 or biphasic human insulin 30.
Povprečni HbA1c je ostal v obeh terapevtskih skupinah ves čas preskušanja podoben izhodiščnemu; delež hipoglikemij se med uporabo zdravila NovoMix 30 ali bifaznega humanega insulina 30 ni razlikoval.
What NovoMix 70 is and what it is used for
Kaj je zdravilo NovoMix 70 in za kaj ga uporabljamo
NovoMix 70 must not be administered intravenously, as it may result in severe hypoglycaemia.
Zdravila NovoMix 70 se ne sme aplicirati intravensko, ker lahko povzroči hudo hipoglikemijo.
• If you have any further questions, ask your doctor, nurse or pharmacist.
• Če imate dodatna vprašanja, se posvetujte z zdravnikom, medicinsko sestro ali s farmacevtom.
NovoMix 30 must not be administered intravenously, as it may result in severe hypoglycaemia.
Zdravila NovoMix 30 se ne sme aplicirati intravensko, ker lahko povzroči hudo hipoglikemijo.
► Always make sure that you have resuspended the insulin prior to each injection.
► Pred vsakim injiciranjem morate insulin resuspendirati.
3 ml suspension in cartridge (type 1 glass) with a plunger (bromobutyl) and a rubber closure (bromobutyl/polyisoprene).
3 ml suspenzije v vložku (steklo tipa I) z batom (bromobutil) in gumijasto zaporko
NovoMix 30 must be protected from excessive heat and light.
Zdravilo NovoMix 30 je treba zaščititi pred čezmerno toploto in svetlobo.
Figure 1: Activity Profile for NovoMix 70 in Healthy Caucasian Subjects.
Slika 1: Profil delovanja zdravila NovoMix 70 pri zdravih belcih
If you take too much insulin, your blood sugar gets too low (hypoglycaemia).
Če ste si injicirali preveč insulina, se vam lahko krvni sladkor preveč zniža (hipoglikemija).
NovoMix 70 dosing is individual and determined in accordance with the needs of the patient.
Odmerjanje zdravila NovoMix 70 je individualno in določeno v skladu z bolnikovimi potrebami.
Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting.
Farmakoterapevtska skupina: zdravila za zdravljenje sladkorne bolezni, insulini in analogi za injiciranje s srednjedolgim ali dolgotrajnim delovanjem s takojšnjim učinkom.
NovoMix 50 may be used in combination with metformin.
Zdravilo NovoMix 50 se lahko uporablja v kombinaciji z metforminom.
In patients with type 2 diabetes, NovoMix 50 can be given as monotherapy or in combination with metformin when the blood glucose is inadequately controlled with metformin alone.
Pri bolnikih s sladkorno boleznijo tipa 2 lahko zdravilo NovoMix 50 uporabite kot monoterapijo ali v kombinaciji z metforminom, če glukoza v krvi s samim metforminom ni zadostno urejena.
• Let the insulin reach room temperature before you use it.
• Preden uporabite vložek, ga pustite da doseže sobno temperaturo.
In elderly patients, glucose monitoring should be intensified and the insulin aspart dose adjusted on an individual basis.
Pri starejših bolnikih je treba koncentracijo glukoze v krvi spremljati pozorneje ter odmerek insulina aspart prilagoditi posamezniku.
NovoMix 30 dosing is individual and determined in accordance with the needs of the patient.
Odmerjanje zdravila NovoMix 30 je individualno in določeno v skladu z bolnikovimi potrebami.
There is limited clinical experience with NovoMix 30 in children aged 6-9 years (see section 5.1).
do 9. leta starosti je kliničnih izkušenj malo (glejte poglavje 5.1).
NovoMix 30 may fully or partially meet this requirement.
Zdravilo NovoMix 30 lahko to potrebo pokrije delno ali v celoti.
What NovoMix 50 is and what it is used for
Kaj je zdravilo NovoMix 50 in za kaj ga uporabljamo
NovoMix 50 dosing is individual and determined in accordance with the needs of the patient.
Odmerjanje zdravila NovoMix 50 je individualno in določeno v skladu z bolnikovimi potrebami.
Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila:
What NovoMix 70 is and what it is used for What you need to know before you use NovoMix 70 How to use NovoMix 70
Kaj je zdravilo NovoMix 70 in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo NovoMix 70 Kako uporabljati zdravilo NovoMix 70
The following substances may reduce the patient's insulin requirements: Oral antidiabetic medicinal products, monoamine oxidase inhibitors (MAOI), beta-blockers, angiotensin converting enzyme (ACE) inhibitors, salicylates, anabolic steroids and sulfonamides.
Bolnikovo potrebo po insulinu lahko zmanjšajo naslednje snovi: peroralni antidiabetiki, zaviralci monoaminooksidaze (MAO), zaviralci adrenergičnih receptorjev beta, zaviralci encima angiotenzinske konvertaze (ACE), salicilati, anabolni steroidi in sulfonamidi.
In patients with renal or hepatic impairment, glucose monitoring should be intensified and the insulin aspart dose adjusted on an individual basis.
Pri bolnikih z ledvično ali jetrno okvaro je treba koncentracijo glukoze v krvi spremljati pozorneje ter odmerek insulina aspart prilagoditi posamezniku.
Pack sizes of 1 (with or without needles), 5 (without needles) and 10 (without needles) pre-filled pens of 3 ml.
Pakiranja z 1 (z iglami ali brez), 5 (brez igel) in 10 (brez igel) napolnjenimi injekcijskimi peresniki po 3 ml. Na trgu morda ni vseh navedenih pakiranj.
The influence of different injection sites on the absorption of NovoMix 70 has not been investigated.
Vpliv različnih mest injiciranja na absorpcijo zdravila NovoMix 70 ni raziskan.
In patients with type 2 diabetes, a meta-analysis showed a reduced risk of overall nocturnal hypoglycaemic episodes and major hypoglycaemia with NovoMix 30 compared to biphasic human insulin 30.
Metaanaliza je pri bolnikih s sladkorno boleznijo tipa 2 pokazala manjše tveganje vseh nočnih hipoglikemij in hudih hipoglikemij med uporabo zdravila NovoMix 30 kot med uporabo dvofaznega humanega insulina 30.
In a 3 month trial in patients with type 1 and type 2 diabetes, NovoMix 30 showed equal control of glycosylated haemoglobin compared to treatment with biphasic human insulin 30.
V 3-mesečnem preskušanju bolnikov s sladkorno boleznijo tipa 1 in tipa 2 je bila urejenost glikiranega hemoglobina z zdravilom NovoMix 30 enaka kot med zdravljenjem z dvofaznim humanim insulinom 30.
See Instructions for use.
Navodilo za uporabo